Becker's Healthcare May 24, 2024
Cameron Cortigiano

An advisory committee to the FDA voted that a blood test that screens for colon and rectal cancers was safe, according to a May 23 report by The New York Times.

The test, designed by Guardant Health, offers an alternative to a colonoscopy or self-administered fecal test for individuals with an average risk for colon and rectal cancers.

However, blood tests are not as effective as colonoscopies at...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
FDA nominee pitches AI application review
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Project Optimus: The evolution of dose optimisation in oncology
Califf: Do right by AI and patients

Share This Article